Login / Signup

PD-1/PD-L1 Inhibitor Combined with Chemotherapy Can Improve the Survival of Non-Small Cell Lung Cancer Patients with Brain Metastases.

Chenglong SunFei ZhouXuefei LiChao ZhaoWei LiJiayu LiAnwen XiongJia YuGuanghui GaoQi WangFengying WuCaicun Zhou
Published in: OncoTargets and therapy (2020)
ICIs combined with chemotherapy demonstrated survival benefits over ICI monotherapy in patients with NSCLCs and BMs.
Keyphrases
  • brain metastases
  • small cell lung cancer
  • locally advanced
  • free survival
  • squamous cell carcinoma
  • open label
  • rectal cancer
  • radiation therapy